{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:32:13Z","timestamp":1789648333852,"version":"4.0.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jss.2023.08.047","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:32:25Z","timestamp":1696915945000},"page":"458-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis"],"prefix":"10.1016","volume":"293","author":[{"given":"Hui-Ying","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Wui","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Hsuan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2023.08.047_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer (IBC)","volume":"22","author":"Anderson","year":"2005","journal-title":"Breast Dis"},{"key":"10.1016\/j.jss.2023.08.047_bib2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jss.2023.08.047_bib3","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.2147\/IJN.S141164","article-title":"Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars","volume":"12","author":"Crawford","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jss.2023.08.047_bib4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/cncr.22927","article-title":"Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease","volume":"110","author":"Cristofanilli","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2023.08.047_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-015-3436-x","article-title":"Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis","volume":"152","author":"Fouad","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2023.08.047_bib6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.1992.10.6.1014","article-title":"Inflammatory breast cancer: a review","volume":"10","author":"Jaiyesimi","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9610(91)90077-Q","article-title":"Results of radical radiotherapy for inflammatory breast cancer","volume":"162","author":"Lamb","year":"1991","journal-title":"Am J Surg"},{"key":"10.1016\/j.jss.2023.08.047_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.suronc.2020.11.008","article-title":"The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: surgical results from a phase II randomized controlled trial","volume":"36","author":"Yamaguchi","year":"2021","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.21037\/gs.2018.08.04","article-title":"Inflammatory breast cancer: no longer an absolute contraindication for breast conservation surgery following good response to neoadjuvant therapy","volume":"7","author":"Brzezinska","year":"2018","journal-title":"Gland Surg"},{"key":"10.1016\/j.jss.2023.08.047_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.breast.2017.06.002","article-title":"A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: a large population-based study in the Surveillance, Epidemiology, and End Results database 18","volume":"35","author":"Chen","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.jss.2023.08.047_bib11","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"23","author":"Lyman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib12","series-title":"NCCN guidelines version 8.2021 2021","year":"2021"},{"key":"10.1016\/j.jss.2023.08.047_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/07357907.2018.1564325","article-title":"Clinical response to induction chemotherapy predicts outcome after combined-modality therapy in inflammatory breast cancer","volume":"37","author":"Loi","year":"2019","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jss.2023.08.047_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/archsurg.1988.01400320037006","article-title":"Multimodality treatment of locally advanced breast carcinoma","volume":"123","author":"Hobar","year":"1988","journal-title":"Arch Surg"},{"key":"10.1016\/j.jss.2023.08.047_bib15","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jss.2023.08.047_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jss.2023.08.047_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0360-3016(99)00019-X","article-title":"Accelerated superfractionated radiotherapy for inflammatory breast carcinoma: complete response predicts outcome and allows for breast conservation","volume":"44","author":"Arthur","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jss.2023.08.047_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.breast.2012.02.002","article-title":"Primary chemo-radiotherapy in the treatment of locally advanced and inflammatory breast cancer","volume":"21","author":"Bates","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.jss.2023.08.047_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1177\/000313481408001006","article-title":"Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy","volume":"80","author":"Bonev","year":"2014","journal-title":"Am Surg"},{"key":"10.1016\/j.jss.2023.08.047_bib20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/1097-0142(19880315)61:6<1096::AID-CNCR2820610608>3.0.CO;2-Y","article-title":"Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation","volume":"61","author":"Brun","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2023.08.047_bib21","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000658-200209000-00006","article-title":"Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival","volume":"236","author":"Cance","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2023.08.047_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/BF02303668","article-title":"Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma","volume":"4","author":"Fleming","year":"1997","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6603987","article-title":"Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up","volume":"97","author":"Genet","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2023.08.047_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/1097-0142(19860101)57:1<24::AID-CNCR2820570107>3.0.CO;2-2","article-title":"Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. A phase II study of 25 cases with a median follow-up of 35 months","volume":"57","author":"Isra\u00ebl","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2023.08.047_bib25","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1245\/s10434-020-09392-8","article-title":"The role of mastectomy in de novo stage IV inflammatory breast cancer","volume":"28","author":"Partain","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.bbmt.2009.04.018","article-title":"Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy","volume":"15","author":"Sport\u00e8s","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jss.2023.08.047_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/02841869509093650","article-title":"Combined chemotherapy, radiotherapy and surgery in inflammatory breast carcinoma","volume":"34","author":"Verg\u00e9s","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib28","first-page":"869","article-title":"Avm (adriamycin, vinblastine, methotrexate) neoadjuvant chemotherapy in advanced or inflammatory carcinoma of the breast","volume":"3","author":"Zola","year":"1993","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-016-4017-3","article-title":"Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery","volume":"160","author":"Brzezinska","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2023.08.047_bib30","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.clbc.2017.06.014","article-title":"Prospective feasibility trial of sentinel lymph node biopsy in the setting of inflammatory breast cancer","volume":"18","author":"DeSnyder","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jss.2023.08.047_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijsu.2009.04.012","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer","volume":"7","author":"Hidar","year":"2009","journal-title":"Int J Surg"},{"key":"10.1016\/j.jss.2023.08.047_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000512202","article-title":"Sentinel lymph node biopsy may prevent unnecessary axillary dissection in patients with inflammatory breast cancer who respond to systemic treatment","volume":"16","author":"Karanlik","year":"2021","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.jss.2023.08.047_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02573060","article-title":"Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer","volume":"9","author":"Stearns","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0360-3016(89)90436-7","article-title":"Inflammatory carcinoma of the breast: treatment results on 107 patients","volume":"17","author":"Fields","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jss.2023.08.047_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0360-3016(89)90060-6","article-title":"Multimodal treatment for inflammatory breast cancer","volume":"17","author":"Thoms","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jss.2023.08.047_bib36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1245\/ASO.2004.02.003","article-title":"Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy","volume":"11","author":"Shen","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/00015458.2005.11679668","article-title":"Breast conserving surgery after primary chemotherapy in locally advanced breast cancer","volume":"105","author":"Asoglu","year":"2005","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.jss.2023.08.047_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1008337009350","article-title":"Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergoni\u00e9 Bordeaux Groupe Sein (IBBGS)","volume":"10","author":"Mauriac","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib39","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/1097-0142(19920601)69:11<2849::AID-CNCR2820691134>3.0.CO;2-P","article-title":"Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma","volume":"69","author":"Singletary","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2023.08.047_bib40","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1245\/s10434-019-07597-0","article-title":"Axillary pathologic complete response in inflammatory breast cancer patients: implications for SLNB?","volume":"26","author":"Imeokparia","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib41","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1245\/s10434-020-08891-y","article-title":"Factors associated with pathological node negativity in inflammatory breast cancer: are there patients who may be candidates for a de-escalation of axillary surgery?","volume":"27","author":"Postlewait","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10549-020-05529-1","article-title":"Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients","volume":"180","author":"Fayanju","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jss.2023.08.047_bib43","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1245\/s10434-021-11297-z","article-title":"Outcomes of sentinel node biopsy for women with breast cancer after neoadjuvant therapy: systematic review and meta-analysis of real-world data","volume":"29","author":"Lin","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib44","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2023.08.047_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423004559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480423004559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:07:05Z","timestamp":1758380825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480423004559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"alternative-id":["S0022480423004559"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2023.08.047","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Breast-Conserving Therapy in Patients With Inflammatory Breast Cancer: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2023.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}